Sugi Predict

Sugi Predict / Compounds / Azaserine

Azaserine

Azaserine

SCHEMBL3312110

[N-]=[N+]=CC(=O)OCC(N)C(=O)O.[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC1A5 Q15758 1/20 0.38
▸ NOS3 P29474 1/20 0.37
▸ NOS1 P29475 1/20 0.37
▸ NOS2 P35228 1/20 0.37
▸ IDO1 P14902 2/20 0.36
▸ PTGS1 P23219 1/20 0.34
▸ SLC7A11 Q9UPY5 1/20 0.34
▸ GFPT1 Q06210 1/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ GRIK1 P39086 6/20 0.32
▸ GRIK2 Q13002 5/20 0.32
▸ GSR P00390 2/20 0.32
▸ SLC1A1 P43005 2/20 0.32
▸ GRM1 Q13255 2/20 0.32
▸ GRM2 Q14416 2/20 0.32
▸ GRIA2 P42262 2/20 0.32
▸ GRIA4 P48058 2/20 0.32
▸ GRIK3 Q13003 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Azaserine SCHEMBL8862 1.00 SLC1A5 (0.38) SLC1A5NOS3NOS1NOS2IDO1
Azaserine SCHEMBL8861 1.00 SLC1A5 (0.38) SLC1A5NOS3NOS1NOS2IDO1
Azaserine SCHEMBL487222 1.00 SLC1A5 (0.38) SLC1A5NOS3NOS1NOS2IDO1
Azaserine SCHEMBL27500218 0.98 SLC1A5 (0.37) SLC1A5NOS3NOS1NOS2IDO1
Azaserine SCHEMBL607082 0.98 SLC1A5 (0.37) SLC1A5NOS3NOS1NOS2IDO1
SCHEMBL607081 0.84 — —
Azaserine SCHEMBL6824548 0.82 ALOX15 (0.47) NOS3NOS1NOS2CYP1A2GRIK1
SCHEMBL31237462 0.81 IDO1 (0.40) SLC1A5NOS3NOS1NOS2IDO1
SCHEMBL26934495 0.81 IDO1 (0.40) SLC1A5NOS3NOS1NOS2IDO1
Azaserine SCHEMBL81760 0.78 ALDH1A1 (0.41) SLC1A5IDO1SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100113386-A1 N-BENZYL SUBSTITUTED PYRIDYL PORPHYRIN COMPOUNDS AND METHODS OF USE THEREOF INOTEK PHARMACEUTICALS CORPORATION (US) 2010-05-06 — — US disclosed
US-7642250-B2 N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof INOTEK PHARMACEUTICALS CORPORATION (US) 2010-01-05 — — US disclosed
EP-1928467-A2 N-BENZYL SUBSTITUTED PYRIDYL PORPHYRIN COMPOUNDS AND METHODS OF USE THEREOF Inotek Pharmaceuticals Corporation (US) 2008-06-11 — — EP disclosed
WO-2007038630-A2 N-BENZYL SUBSTITUTED PYRIDYL PORPHYRIN COMPOUNDS AND METHODS OF USE THEREOF INOTEK PHARMACEUTICALS CORPORATION (US) 2007-04-05 — — WO disclosed
US-20070072825-A1 N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof INOTEK PHARMACEUTICALS CORPORATION (US) 2007-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113386-A1 N-BENZYL SUBSTITUTED PYRIDYL PORPHYRIN COMPOUNDS AND METHODS OF USE THEREOF PPOX, PPIF, COX5A SLC1A5 1172/4885NOS3 330/4885NOS1 190/4885
US-20070072825-A1 N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof PPOX, PPIF, COX5A SLC1A5 1172/4885NOS3 330/4885NOS1 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.